{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:45:48Z","timestamp":1787683548457,"version":"build-2784847793"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtos.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:20:41Z","timestamp":1772731241000},"page":"216-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical evidence on allogeneic blood-derived eye drops in ocular surface and corneal diseases"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6768-2830","authenticated-orcid":false,"given":"Seyyedehfatemeh","family":"Ghalibafan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansu Ann","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Djalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6383-2558","authenticated-orcid":false,"given":"Alfonso L.","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jtos.2026.03.002_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jop.2023.0155","article-title":"Blood-derived eye drops for the treatment of corneal neuropathic pain","volume":"40","author":"Anam","year":"2024","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"9","key":"10.1016\/j.jtos.2026.03.002_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091478","article-title":"Blood-based treatments for severe dry eye disease: the need of a consensus","volume":"8","author":"Bernabei","year":"2019","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.jtos.2026.03.002_bib3","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41433-023-02904-2","article-title":"Efficacy of plasma rich in growth factors (PRGF) in stage 1 neurotrophic keratitis","volume":"38","author":"Ghalibafan","year":"2024","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000542731","article-title":"Therapeutic effects of umbilical cord serum for dry eye disease: a systemic review and meta-analysis","volume":"68","author":"Li","year":"2025","journal-title":"Ophthalmic Res"},{"issue":"9","key":"10.1016\/j.jtos.2026.03.002_bib5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/ICO.0000000000002943","article-title":"Short-term efficacy and safety of biological tear substitutes and topical secretagogues for dry eye disease: a systematic review and network meta-analysis","volume":"41","author":"Jongkhajornpong","year":"2022","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood derived eye drops for the treatment of cornea and ocular surface diseases","volume":"56","author":"Giannaccare","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtos.2026.03.002_bib7","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.2147\/OPTH.S265701","article-title":"Human platelets and derived products in treating ocular surface diseases - a systematic review","volume":"14","author":"You","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2026.03.002_bib8","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1007\/s40123-023-00827-5","article-title":"Allogeneic serum eye drops: a randomized clinical trial to evaluate the clinical effectiveness of two drop sizes","volume":"12","author":"Vermeulen","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.jtos.2026.03.002_bib9","first-page":"200","article-title":"Serum eye drops for the treatment of ocular surface diseases: a systematic review and meta-analysis","volume":"17","author":"Franchini","year":"2019","journal-title":"Blood Transfus"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib10","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1111\/aos.17450","article-title":"CORONIS symposium 2023: scientific and clinical frontiers in ocular surface innervation","volume":"103","author":"Galor","year":"2025","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jtos.2026.03.002_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1500160","article-title":"Blood component therapy for dry eye disease: a systematic review and network meta-analysis","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.jtos.2026.03.002_bib12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00347-008-1751-x","article-title":"[Legal regulations to produce serum eye drops : when is it necessary, and how can it be obtained?]","volume":"105","author":"Geerling","year":"2008","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.jtos.2026.03.002_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jclinepi.2019.11.010","article-title":"Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines","volume":"118","author":"Page","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jtos.2026.03.002_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.11124\/JBIES-22-00125","article-title":"Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid Synth"},{"issue":"3","key":"10.1016\/j.jtos.2026.03.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2024.103912","article-title":"Correlation between serum cytokine levels and the effect of allogeneic serum-based eye drops","volume":"63","author":"Chmielewska","year":"2024","journal-title":"Transfus Apher Sci"},{"issue":"5","key":"10.1016\/j.jtos.2026.03.002_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2024.103991","article-title":"Allogeneic serum-based eye drops may give better results than autologous drops in Sj\u00f6gren's syndrome dry eye","volume":"63","author":"Janus","year":"2024","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtos.2026.03.002_bib17","article-title":"Use of allogeneic platelet-rich plasma for the treatment of autoimmune ocular surface disorders: case series","volume":"3","author":"Mancini","year":"2023","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"10.1016\/j.jtos.2026.03.002_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1252688","article-title":"Patient-reported outcomes of serum eye drops manufactured from Australian blood donations and packaged using Meise vials","volume":"10","author":"Gemelli","year":"2023","journal-title":"Front Med"},{"issue":"21","key":"10.1016\/j.jtos.2026.03.002_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216750","article-title":"Allogeneic umbilical cord plasma eyedrops for the treatment of recalcitrant dry eye disease patients","volume":"12","author":"Wong","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtos.2026.03.002_bib20","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.2147\/OPTH.S385078","article-title":"Treatment of severe dry eye in Stevens-Johnson syndrome with umbilical cord serum eye drops","volume":"16","author":"Susiyanti","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2026.03.002_bib21","article-title":"Therapeutic Hyper-CL soft contact lens in Sj\u00f6gren's syndrome","volume":"28","author":"Romano","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"2","key":"10.1016\/j.jtos.2026.03.002_bib22","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1111\/aos.14953","article-title":"Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double-blind randomized clinical trial","volume":"100","author":"Rodr\u00edguez Calvo-de-Mora","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2026.03.002_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/aos.14788","article-title":"Allogeneic and autologous serum eye drops: a pilot double-blind randomized crossover trial","volume":"99","author":"van der Meer","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2026.03.002_bib24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/bjophthalmol-2019-314859","article-title":"Blood derived treatment from two allogeneic sources for severe dry eye associated to keratopathy: a multicentre randomised cross over clinical trial","volume":"104","author":"Campos","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2026.03.002_bib25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/ICO.0000000000002005","article-title":"In vivo confocal microscopy automated morphometric analysis of corneal subbasal nerve plexus in patients with dry eye treated with different sources of homologous serum eye drops","volume":"38","author":"Giannaccare","year":"2019","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/bjophthalmol-2013-304801","article-title":"Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen's disease: a tear proteomic study","volume":"99","author":"Mukhopadhyay","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/ICO.0b013e3182580762","article-title":"Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye","volume":"32","author":"Versura","year":"2013","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2026.03.002_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/jop.2012.0002","article-title":"Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease","volume":"28","author":"Na","year":"2012","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bmt.1705566","article-title":"Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease","volume":"39","author":"Yoon","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtos.2026.03.002_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","article-title":"Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"26","author":"Chiang","year":"2007","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2007.03.016","article-title":"Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome","volume":"144","author":"Yoon","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2026.03.002_bib32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.ico.0000183484.85636.b6","article-title":"Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome","volume":"25","author":"Yoon","year":"2006","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2026.03.002_bib33","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s40123-025-01211-1","article-title":"Real-world outcomes of allogeneic immunosafe plasma rich in growth factors eye drops for refractory ocular surface diseases: a prospective observational study","volume":"14","author":"Alvarado-Villacorta","year":"2025","journal-title":"Ophthalmol Ther"},{"issue":"10","key":"10.1016\/j.jtos.2026.03.002_bib34","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s00417-025-06870-1","article-title":"Allogeneic fresh frozen plasma eye drops for the treatment of ocular graft-versus-host disease: prospective open-label study","volume":"263","author":"Nahum","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2026.03.002_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/life14101268","article-title":"Umbilical cord blood platelet lysate eyedrops for the treatment of severe ocular surface disorders in graft vs. host disease patients: clinical study","volume":"14","author":"Gagliano","year":"2024","journal-title":"Life"},{"issue":"11","key":"10.1016\/j.jtos.2026.03.002_bib36","article-title":"Umbilical cord blood-derived products in autoimmune systemic syndromes with severe dryness: a pilot study","volume":"60","author":"Foti","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/jop.2022.0107","article-title":"Therapeutic profile of human umbilical cord blood serum and autologous serum therapies in treatment of ocular surface disorders: a pilot study","volume":"39","author":"Kumar","year":"2023","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib38","first-page":"347","article-title":"Clinical evaluation of allogeneic eye drops from cord blood platelet lysate","volume":"19","author":"Samarkanova","year":"2021","journal-title":"Blood Transfus"},{"issue":"12","key":"10.1016\/j.jtos.2026.03.002_bib39","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1038\/s41433-021-01560-8","article-title":"Patient-reported outcome measures for a large cohort of serum eye drops recipients in the UK","volume":"35","author":"Lomas","year":"2021","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/tme.12572","article-title":"A retrospective crossover study of autologous and allogeneic serum eye drops for the management of ocular surface disease","volume":"29","author":"Hung","year":"2019","journal-title":"Transfus Med"},{"key":"10.1016\/j.jtos.2026.03.002_bib41","article-title":"Topical treatment with cord blood serum in glaucoma patients: a preliminary report","author":"Campos","year":"2018","journal-title":"Case Rep Ophthalmol Med"},{"issue":"8","key":"10.1016\/j.jtos.2026.03.002_bib42","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/ICO.0000000000001257","article-title":"Efficacy of 2-Month treatment with cord blood serum eye drops in ocular surface disease: an in vivo confocal microscopy study","volume":"36","author":"Giannaccare","year":"2017","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.jtos.2026.03.002_bib43","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/aos.12386","article-title":"Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy","volume":"92","author":"Harritsh\u00f8j","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib44","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/j.1755-3768.2012.02538.x","article-title":"Application of umbilical cord serum eyedrops after laser epithelial keratomileusis","volume":"91","author":"Yoon","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2026.03.002_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0000000000002573","article-title":"Anterior segment surgeries under topical fresh frozen plasma treatment in ligneous conjunctivitis","volume":"40","author":"Ozbek-Uzman","year":"2021","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9394(01)01433-7","article-title":"Effective treatment of ligneous conjunctivitis with topical plasminogen","volume":"133","author":"Watts","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/ICO.0b013e31818754ac","article-title":"Fresh frozen plasma treatment of ligneous conjunctivitis: use of heparin and allogeneic serum","volume":"28","author":"Lee","year":"2009","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib48","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/ICO.0b013e318162a8e0","article-title":"Systemic and topical fresh-frozen plasma treatment in a newborn with ligneous conjunctivitis","volume":"27","author":"G\u00fcrl\u00fc","year":"2008","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.14744\/bej.2024.98470","article-title":"Ligneous conjunctivitis with plasminogen deficiency treated with topical allogeneic serum drops: a case report","volume":"10","author":"Ozkan","year":"2025","journal-title":"Beyoglu Eye J"},{"issue":"2","key":"10.1016\/j.jtos.2026.03.002_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ajo.2004.02.067","article-title":"Prevention of ligneous conjunctivitis by topical and subconjunctival fresh frozen plasma","volume":"138","author":"Tabbara","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2026.03.002_bib51","article-title":"Ligneous conjunctivitis: Fresh-frozen plasma and heparin use intra-and postoperatively, a report of two cases","volume":"87","author":"Almeida","year":"2024","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jtos.2026.03.002_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2023.108568","article-title":"Combined medical and surgical approach in the management of ligneous conjunctivitis in a pediatric patient: a case report","volume":"110","author":"Ahmad","year":"2023","journal-title":"Int J Surg Case Rep"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaapos.2020.09.004","article-title":"Treatment of ligneous conjunctivitis with fresh frozen plasm in twin babies","volume":"25","author":"Yurttaser Ocak","year":"2021","journal-title":"J AAPOS"},{"issue":"5","key":"10.1016\/j.jtos.2026.03.002_bib54","doi-asserted-by":"crossref","first-page":"Np1","DOI":"10.1177\/11206721211018373","article-title":"Ligneous conjunctivitis associated with type I plasminogen deficiency: a rare case","volume":"32","author":"Dimopoulos","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2026.03.002_bib55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5935\/0004-2749.20150083","article-title":"Successful treatment of ligneous conjunctivitis with topical fresh frozen plasma in an infant","volume":"78","author":"Tunay","year":"2015","journal-title":"Arq Bras Oftalmol"},{"issue":"6","key":"10.1016\/j.jtos.2026.03.002_bib56","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/08820538.2015.1005319","article-title":"Adult-onset ligneous conjunctivitis with detection of a novel plasminogen gene mutation and anti-plasminogen IgA antibody: a clinicopathologic study and review of literature","volume":"31","author":"Tu","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2026.03.002_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3341\/kjo.2005.19.3.174","article-title":"Therapeutic effect of umbilical cord serum eyedrops for persistent corneal epithelial defect","volume":"19","author":"Yoon","year":"2005","journal-title":"Kor J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2026.03.002_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.eye.6703079","article-title":"Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect","volume":"23","author":"Chiang","year":"2009","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.jtos.2026.03.002_bib59","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/ICO.0000000000001512","article-title":"Maternal serum eye drops in the management of pediatric persistent corneal epithelial defects: a case series","volume":"37","author":"Kalhorn","year":"2018","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.jtos.2026.03.002_bib60","first-page":"807","article-title":"Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects","volume":"7","author":"Erdem","year":"2014","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib61","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/ICO.0000000000003204","article-title":"Allogeneic solid platelet-rich plasma for persistent epithelial neurotrophic defects: a protocol and pilot study","volume":"42","author":"Romano","year":"2023","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-241138","article-title":"Maternal finger-prick allogenic blood for persistent corneal epithelial defects","volume":"14","author":"Pujari","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"11","key":"10.1016\/j.jtos.2026.03.002_bib63","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bjo.87.11.1312","article-title":"Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects","volume":"87","author":"Vajpayee","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2026.03.002_bib64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/ICL.0000000000000277","article-title":"Evaluation of the role of umbilical cord serum and autologous serum therapy in reepithelialization after keratoplasty: a randomized controlled clinical trial","volume":"43","author":"Kamble","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.51329\/mehdiophthal1463","article-title":"Safety and efficacy of eye drops from umbilical cord blood platelet lysate to treat resistant corneal ulcer","volume":"11","author":"Farag","year":"2022","journal-title":"Med Hypothesis, Discov Innovation (MEHDI) Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2026.03.002_bib65","doi-asserted-by":"crossref","DOI":"10.4103\/djo.djo_17_23","article-title":"Evaluation of the effect of umbilical cord blood serum therapy in resistant infected corneal ulcer","volume":"24","author":"Elsawy","year":"2023","journal-title":"Delta J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2026.03.002_bib67","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/ICO.0b013e31820d850f","article-title":"Application of umbilical cord serum eyedrops for recurrent corneal erosions","volume":"30","author":"Yoon","year":"2011","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.jtos.2026.03.002_bib68","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.ophtha.2006.12.014","article-title":"Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis","volume":"114","author":"Yoon","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2026.03.002_bib69","first-page":"277","article-title":"Synergistic effect of regenerating agent plus cord blood serum eye drops for the treatment of resistant neurotrophic keratitis: a case report and a hypothesis for pathophysiologic mechanism","volume":"8","author":"Giannaccare","year":"2015","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.jtos.2026.03.002_bib70","article-title":"Maternal serum eye drops to treat bilateral neurotrophic keratopathy in congenital corneal anesthesia: case report and literature review","volume":"26","author":"Giannaccare","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"6","key":"10.1016\/j.jtos.2026.03.002_bib71","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4274\/tjo.galenos.2021.93384","article-title":"Palytoxin-related keratoconjunctivitis assessed by high-resolution anterior segment optical coherence tomography","volume":"51","author":"Marti","year":"2021","journal-title":"Turk J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2026.03.002_bib72","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1167\/iovs.09-4170","article-title":"Evaluation of umbilical cord serum therapy in acute ocular chemical burns","volume":"52","author":"Sharma","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2026.03.002_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajo.2016.05.010","article-title":"Comparison of amniotic membrane transplantation and umbilical cord serum in acute ocular chemical burns: a randomized controlled trial","volume":"168","author":"Sharma","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.transci.2015.05.013","volume":"53","author":"Seghatchian","year":"2015","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib75","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/eye.2016.268","article-title":"Allogeneic blood-based therapies: hype or hope?","volume":"31","author":"Anitua","year":"2017","journal-title":"Eye (Lond)"},{"issue":"21","key":"10.1016\/j.jtos.2026.03.002_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110782","article-title":"Allogeneic umbilical cord blood serum eyedrops for the treatment of severe dry eye disease patients","volume":"26","author":"Zeppieri","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10.1016\/j.jtos.2026.03.002_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211097","article-title":"Blood derivatives in the therapy of ocular surface diseases","volume":"26","author":"St\u0119pie\u0144","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib78","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4103\/IJO.IJO_482_25","article-title":"Biological topicals in ocular surface disorders","volume":"73","author":"Nair","year":"2025","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2026.03.002_bib79","doi-asserted-by":"crossref","first-page":"699","DOI":"10.21873\/invivo.12310","article-title":"Regenerative therapy using umbilical cord serum","volume":"35","author":"Maharajan","year":"2021","journal-title":"In Vivo (Athens)"},{"issue":"2","key":"10.1016\/j.jtos.2026.03.002_bib80","first-page":"145","article-title":"Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops","volume":"14","author":"Versura","year":"2016","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtos.2026.03.002_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1384500","article-title":"Elucidating the mechanism of corneal epithelial cell repair: unraveling the impact of growth factors","volume":"11","author":"Gong","year":"2024","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.jtos.2026.03.002_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.102091","article-title":"Platelet-rich plasma for treating dry eye disease - a systematic review and meta-analysis","volume":"47","author":"Kwaku Akowuah","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2026.03.002_bib83","first-page":"s44","article-title":"Cord blood serum-based eye drops: the impact of donor haematological and obstetric factors on the variability of epidermal growth factor levels","volume":"12","author":"Versura","year":"2014","journal-title":"Blood Transfus"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103155","article-title":"Metabolomics comparison of cord and peripheral blood-derived serum eye drops for the treatment of dry eye disease","volume":"60","author":"Quartieri","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.jtos.2026.03.002_bib85","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.transci.2018.06.001","article-title":"Comparison of growth factor and interleukin content of adult peripheral blood and cord blood serum eye drops for cornea and ocular surface diseases","volume":"57","author":"Buzzi","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.jtos.2026.03.002_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021567","article-title":"Development of in vitro dry eye models to study proliferative and anti-inflammatory effects of allogeneic serum eye drops","volume":"24","author":"Vo\u00df","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.jtos.2026.03.002_bib87","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41577-024-01064-y","article-title":"Redefining our vision: an updated guide to the ocular immune system","volume":"24","author":"Wu","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.jtos.2026.03.002_bib88","doi-asserted-by":"crossref","first-page":"sxaf048","DOI":"10.1093\/stmcls\/sxaf048","article-title":"Clinical evidence and critical review of mesenchymal stromal cells for corneal and ocular surface diseases","volume":"43","author":"Tu","year":"2025","journal-title":"Stem Cell"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012426000327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012426000327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:42:56Z","timestamp":1782189776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012426000327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":88,"alternative-id":["S1542012426000327"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2026.03.002","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical evidence on allogeneic blood-derived eye drops in ocular surface and corneal diseases","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}